• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.

作者信息

Jennings Garry Lr

机构信息

University of Sydney, Sydney, NSW.

Baker Heart and Diabetes Institute, Melbourne, VIC.

出版信息

Med J Aust. 2020 Jun;212(11):502-503.e1. doi: 10.5694/mja2.50622. Epub 2020 May 21.

DOI:10.5694/mja2.50622
PMID:32441063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7280580/
Abstract
摘要

相似文献

1
Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂、血管紧张素II受体阻滞剂与心血管疾病
Med J Aust. 2020 Jun;212(11):502-503.e1. doi: 10.5694/mja2.50622. Epub 2020 May 21.
2
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应？
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
3
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂：证据是什么？
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
4
Drugs and the renin-angiotensin system in covid-19.新冠病毒肺炎中的药物与肾素-血管紧张素系统
BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.
5
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.SARS-CoV-2 的受体 ACE-2 在许多不同的细胞类型上表达：对基于 ACE 抑制剂和血管紧张素 II 受体阻滞剂的心血管治疗的影响。
Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19.
6
A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).关于血管紧张素受体阻滞剂和血管紧张素转换酶抑制剂在2019冠状病毒病（COVID-19）中应用的共识声明。
N Z Med J. 2020 Apr 3;133(1512):85-87.
7
Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统阻滞剂在新型冠状病毒肺炎患者中的疗效：一项系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):335-337. doi: 10.1093/ehjcvp/pvaa074.
8
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂：COVID-19患者结局比较
Circ Cardiovasc Qual Outcomes. 2020 Oct;13(10):e007115. doi: 10.1161/CIRCOUTCOMES.120.007115. Epub 2020 Aug 28.
9
[Renin-angiotensin system blockers and COVID-19 infection].[肾素-血管紧张素系统阻滞剂与新型冠状病毒肺炎感染]
Hipertens Riesgo Vasc. 2020 Jul-Sep;37(3):99-100. doi: 10.1016/j.hipert.2020.04.002. Epub 2020 Apr 16.
10
A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?系统评价和荟萃分析使用肾素-血管紧张素系统药物和 COVID-19 临床结局：迄今为止有哪些证据？
Pharmacol Res Perspect. 2020 Dec;8(6):e00666. doi: 10.1002/prp2.666.

引用本文的文献

1
Impact of the first wave of COVID-19 on stroke admissions across three tertiary hospitals in Brisbane.COVID-19 第一波疫情对布里斯班三家三级医院卒中患者收治的影响。
Intern Med J. 2022 Aug;52(8):1322-1329. doi: 10.1111/imj.15827. Epub 2022 Jul 9.
2
Impact of COVID-19 pandemic on ophthalmic presentations to an Australian outer metropolitan and rural emergency department: a retrospective comparative study.COVID-19 大流行对澳大利亚远郊和农村急诊部门眼科就诊的影响：一项回顾性对比研究。
BMC Ophthalmol. 2022 Jan 28;22(1):40. doi: 10.1186/s12886-022-02271-8.
3
Acute Coronary Syndrome in the COVID-19 Pandemic: Reduced Cases and Increased Ischaemic Time.COVID-19大流行期间的急性冠状动脉综合征：病例减少与缺血时间增加
Heart Lung Circ. 2022 Jan;31(1):69-76. doi: 10.1016/j.hlc.2021.07.023. Epub 2021 Aug 25.
4
The Psychological Impact of Hypertension During COVID-19 Restrictions: Retrospective Case-Control Study.新冠疫情防控期间高血压的心理影响：回顾性病例对照研究
JMIRx Med. 2021 Mar 30;2(1):e25610. doi: 10.2196/25610. eCollection 2021 Jan-Mar.
5
Renin-angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.肾素-血管紧张素系统抑制与 COVID-19 感染和死亡风险：系统评价和荟萃分析。
Intern Med J. 2020 Dec;50(12):1468-1474. doi: 10.1111/imj.15002. Epub 2020 Nov 16.

本文引用的文献

1
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.心血管疾病与 COVID-19：澳大利亚和新西兰共识声明。
Med J Aust. 2020 Aug;213(4):182-187. doi: 10.5694/mja2.50714. Epub 2020 Jul 31.
2
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.自新冠疫情爆发以来奥地利急性冠脉综合征入院人数的下降：疫情应对措施导致心脏附带损害。
Eur Heart J. 2020 May 14;41(19):1852-1853. doi: 10.1093/eurheartj/ehaa314.
3
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.新冠疫情期间美国ST段抬高型心肌梗死导管插入实验室激活率的降低
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872. doi: 10.1016/j.jacc.2020.04.011. Epub 2020 Apr 10.
4
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2：SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂：庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
5
Covid-19: A&E visits in England fall by 25% in week after lockdown.新冠疫情：英国实施封锁措施后的一周内，急诊就诊量下降了25%。
BMJ. 2020 Apr 6;369:m1401. doi: 10.1136/bmj.m1401.
6
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
7
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?在新冠疫情期间，血管紧张素受体阻断药物是否可能有害？
J Hypertens. 2020 May;38(5):781-782. doi: 10.1097/HJH.0000000000002450.
8
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018.澳大利亚国家心脏基金会以及澳大利亚和新西兰心脏学会：《2018年澳大利亚心力衰竭预防、检测与管理指南》
Heart Lung Circ. 2018 Oct;27(10):1123-1208. doi: 10.1016/j.hlc.2018.06.1042.
9
From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension.从基因到蛋白质——ACE2 在血压控制和动脉高血压中的实验和临床研究。
Front Physiol. 2014 Jun 24;5:227. doi: 10.3389/fphys.2014.00227. eCollection 2014.
10
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.肾素-血管紧张素系统阻断对肾脏血管紧张素-（1-7）生成酶及受体的影响。
Kidney Int. 2005 Nov;68(5):2189-96. doi: 10.1111/j.1523-1755.2005.00675.x.